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Background: Substantial antibiotic use and high population densities in intensive farming systems 
results in the emergence and spread of antibiotic-resistant commensals and pathogens. This study 
investigated the molecular epidemiology of antibiotic resistance (ABR) and virulence in Enterococcus 
spp. from pigs in an intensive food production continuum from farm-to-fork in the uMgungundlovu 
district, Kwa-Zulu Natal.  
 
Methods: A total of 174 samples obtained along the pig farm-to-fork continuum (farm, transport, 
abattoir, and retail meat) were subjected to the quantification and putative identification of 
Enterococcus spp. using the IDEXX Enterolert® method and selective media, respectively. Up to three 
presumptive enterococcal colonies were picked per sampling point for molecular confirmation by real-
time PCR, targeting the genus- and species-specific (tuf and sodA) genes, respectively. Antibiotic 
resistance profiles were determined by the Kirby-Bauer disk diffusion method against a panel of 
antibiotics for Enterococcus spp. recommended by the WHO-AGISAR using EUCAST guidelines. 
Selected antibiotic resistance and virulence genes were detected by real-time PCR. Clonal relatedness 
between isolates across the continuum was evaluated by REP-PCR. 
 
Results: A total of 284 isolates constituted the final sample. Real-time PCR confirmed 79.2% of the 
isolates as E. faecalis, 6.7% as E. faecium, 2.5% as E. casseliflavus, 0.4% as E. gallinarum, and 11.2% 
as other Enterococcus spp. Antibiotic susceptibility testing revealed resistance to sulfamethoxazole-
trimethoprim (78.8%), tetracycline (76.9%), erythromycin (68.1%), streptomycin (62.6%), 
chloramphenicol (27.0%), ciprofloxacin (8.5%), gentamicin (8.1%), and levofloxacin (5.6%) but no 
vancomycin, teicoplanin, tigecycline or linezolid resistance was detected. E. faecium displayed 44.4% 
resistance to quinupristin-dalfopristin. A total of 78% of enterococcal isolates were MDR. Phenotypic 
resistance to tetracycline, aminoglycosides, and macrolides was corroborated by the presence of the 
tetM, aph(3’)-IIIa, and ermB genes in 99.1%, 96.1%, and 88.3% of the isolates, respectively. The most 
commonly detected virulence genes were: gelE, efaAfs, and cpd in 89.1%, 78.5%, and 77.1% of isolates 
conferring autolysin and biofilm formation capabilities, cell adhesion, and conjugative plasmid 
accumulation, respectively. Clonality evaluated by REP-PCR revealed that E. faecalis isolates belonged 
to diverse clones along the continuum with major REP-types, largely consisting of isolates from the 
same sampling source but different sampling rounds (on the farm). E. faecium isolates revealed a less 
diverse profile.  There was minimal evidence of clonal transmission across the continuum.   
 
Conclusion: Multi-drug resistant Enterococcus spp. were isolated along the farm-to-fork continuum. 
Isolates harboured a diversity of antibiotic resistance and virulence genes in different combinations 
forming reservoirs for the potential transfer of these genes from pigs to occupationally exposed workers 
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and consumers via direct contact with animals and animal products/food, respectively. The results 
highlight the need for more robust guidelines for antibiotic use in intensive farming practices and the 





INTRODUCTION AND LITERATURE REVIEW 
1.1 Introduction 
“With a lack of development of new antibiotics, and increasing resistance even to last-resort antibiotics, 
there is a need to conserve the ones available” (von Wintersdorff et al., 2016). Globalization has led to 
increased interactions between different regions and populations, meaning that all people and places in 
the world are now interconnected. People and animals are continuously interacting, both with each other 
and their associated environments, and a complex link exists between the indiscriminate use of 
antibiotics and the evolution and dissemination of antibiotic resistance in these three sectors. As the  
population growth rate increases, the demand for food animal products increases, causing  a shift to 
more intensive farming systems where antibiotics are used to not only treat disease but for growth 
promotion, prophylaxis and metaphylaxis to maintain animal health and productivity (Dewulf et al., 
2020). The use of antibiotics, combined with the high population densities of these systems, create 
favorable conditions for the exchange of bacteria and antibiotic resistance genes (ARGs) by exerting 
selection pressure (FAO, 2016). The predicted increase in annual global antibiotic consumption in 
livestock and the increasing emergence of antibiotic-resistant pathogens in animals is a grave public 
health concern (Van Boeckel et al., 2015). Antibiotics used in animal health are often analogues of 
those used in human health, which can serve as a driving force for disseminating resistance determinants 
between animals to humans, and vice versa either by direct contact or via the food chain and 
environment. The degree to which this transmission occurs is of significant interest and has implications 
for human and animal health (Singer et al., 2016). Therefore, the antimicrobial resistance (AMR) crises 
cannot be remedied by addressing one sector and necessitates a One Health approach.  
 
An early example of the relationship between antibiotic use in animals and the incidence and subsequent 
spread of resistance determinants is the use of avoparcin, a glycopeptide structurally related to 
vancomycin, as a growth promoter in chickens and pigs in many European countries from the 1970s 
until it was banned in the late 1990s. This led to the frequent isolation of vancomycin-resistant 
enterococci (VRE) in farm animals and humans alike (Marshall & Levy, 2011). Today, vancomycin is 
considered a last-line antibiotic for the treatment of severe infections caused by Gram-positive 
pathogens.  
 
Enterococcus spp. are Gram-positive commensals present in the gut of humans and animals, but they 
have also emerged as nosocomial pathogens, e.g., VRE, that present a serious challenge to antibiotic 
therapy (WHO, 2017). In light of this, the World Health Organization (WHO) listed vancomycin-
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resistant Enterococcus faecium (VRE. faecium) as a high-priority pathogen for the development of new 
antibiotics.  
 
To fully grasp the complexity of enterococci in causing disease, a greater understanding of their ability 
to survive stresses, their antibiotic resistance, virulence traits, and dissemination pathways are required 
in all the One Health niches they occupy.  While there are some reports of enterococcal infections in 
human health, there is currently limited information available in South Africa on the molecular 
characteristics and distribution of antibiotic-resistant enterococci in intensively produced food animals 
such as pigs. Therefore, it is necessary to investigate antibiotic-resistant Enterococcus spp. along the 
pig production chain, from farm-to-fork, to inform evidence-based measures for its containment. 
1.2 Literature review 
1.2.1 Antibiotic Resistance  
Antimicrobials are medicines used to prevent or cure infections and include antibiotics, antivirals, 
antifungals, and antiparasitics. AMR develops when pathogens are no longer susceptible to these 
medicines. Antibiotic resistance (ABR) refers to bacteria that no longer respond to antibiotics that 
originally killed them and cured the infection (WHO, 2015). This phenomenon may occur naturally but 
has been intensified by the inappropriate use of antibiotics, poor therapy adherence, excessive use of 
antibiotics in food-producing animals, and poor hygiene and sanitation (FAO, 2016). A direct 
consequence of ABR is the failure to successfully treat infections, which leads to increased mortality, 
prolonged illness, and reduced livelihood and food security. This inadvertently results in higher 
alternative treatment costs (O'Neill, 2014). It is estimated that unless urgent action is taken, deaths 
attributable to AMR by 2050 will be 10 million per year, of which approximately 4 million will occur 
in Africa. (O’Neill, 2014). The contribution of animal food production to the AMR crises may be 
debated by some on the grounds that we do not see a significant amount of animal associated infections 
in humans (Robinson et al., 2016). Nevertheless, due to how antibiotics are administered in animal 
production, metaphylactic, prophylactic, and growth-promoting antimicrobials create an ideal 
environment for the selection and dissemination of antibiotic-resistant bacteria through the recurrent 
exposure to low doses of antimicrobial agents (You et al., 2014). These antibiotic resistance genes 
(ARGs) can subsequently be transmitted to human-adapted pathogens or human gut microbiota via 
people, contaminated food, or the environment (Robinson et al., 2016).  
The rise of ABR in animal food production directly increases the probability of animal mortality, and 
the failure to treat resistant infections leads to decreased animal performance. Consequently, it 
decreases the monetary returns in animal food production, resulting in higher food costs for consumers 
(Dewulf et al., 2020). 
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1.2.2 Use of antibiotics in food animals 
Antibiotics are currently used in food animals for treatment and purposes such as disease prevention 
and animal growth promotion. Therapeutic use refers to the use of antibiotics to treat clinically infected 
animals, whereas metaphylaxis involves the administration of antibiotics at therapeutic doses to groups 
of animals when only some individuals in the group are diseased to prevent further spread of the 
infection. Prophylactic use is generally defined as the administration of antibiotics to healthy animals 
to prevent clinical disease (Dewulf et al., 2020). Growth promotion refers to the use of antimicrobial 
substances at sub-therapeutic concentrations to increase growth rates and/or the efficiency of feed 
additives in animals. “The term does not apply to the use of antimicrobials for the specific purpose of 
treating, controlling, or preventing infectious diseases, even when an incidental growth response may 
be obtained” (You & Silbergeld, 2014).  
 
Singer et al., 2016 describes three classes of resistance-driving chemicals, namely antimicrobials (four 
subclasses: antibiotics, antifungals, antivirals, and antiparasitics); heavy metals; and biocides (i.e., 
disinfectants and surfactants) and highlights that antibiotics as well as other chemicals can select for 
resistance genes. Xenobiotics (octanol, hexane, and toluene) are also known to select for resistance 
(Friedman, 2015; Andleeb et al., 2020). Co-selection of genes that confer resistance to xenobiotics, 
biocides, antibiotics, and heavy metals is a “potentially ecologically and clinically” significant 
phenomenon (Singer et al., 2016). Co-selection is achieved in two ways: (1) cross-resistance and (2) 
co-resistance. Cross-resistance involves mechanisms that provide resistance to multiple resistance-
driving chemicals such as antibiotics and heavy metals. For instance, efflux pumps can mediate cross-
resistance to multiple antimicrobials by rapid extrusion of the toxins out of the cell (Seiler & Berendonk, 
2012). The ability of pathogens to co-select genes that confer resistance highlight a fundamental issue 
with the use of antibiotics as growth promoters and feed additives in agriculture as it is not just the 
residual antibiotics in meat but rather the selective pressure exerted by the antibiotics that lead to the 
emergence of multi-drug resistant (MDR) pathogens (You & Silbergeld, 2014; Molechan et al., 2019).  
The use of antibiotics such as avoparcin (a glycopeptide) and tylosin (a macrolide) as growth promoters 
in European countries were associated with a high prevalence of VRE and macrolide-resistant 
enterococci in pigs (Boerlin et al., 2001). This led to a ban throughout the European Union on the use 
of avoparcin. The resulting change found a decrease in the prevalence of VRE in livestock; however, 
this trend was not observed in some European countries (Aarestrup, 2000; Pruksakorn et al., 2016). 
Nowadays, antibiotics such as vancomycin, a glycopeptide antibiotic, belong to the group of “last resort 
antibiotics,” which refer to the last line of effective antibiotics against resistant bacteria. Resistance to 
last-resort antibiotics poses a challenge as minimal treatment options remain. (Molechan et al., 2019; 
Seiler & Berendonk, 2012).  
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“Co-resistance is defined as two or more genetically linked resistance genes, meaning that genes 
responsible for resistance to two or more antimicrobials are located next to each other on one mobile 
genetic element” (Seiler & Berendonk, 2012). As an example, Hasman and Aarestrup (2002) found a 
genetic link between copper (Cu) resistance encoded by the tcrB gene, macrolide resistance encoded by 
the erm(B) gene and glycopeptide resistance encoded by the vanA gene in a plasmid originating from 
E. faecium isolated from a pig in Denmark. Here, co-resistance to Cu and antibiotics, all utilized in farm 
practice was detected. Hasman et al. (2006) later showed that in piglets who were fed increased amounts 
of copper, there was co-selection for erythromycin and vancomycin resistance in enterococcal isolates. 
This indicates a Cu-induced spread of erythromycin and vancomycin resistance genes to antibiotics 
relevant in animal and human health sectors. Amachawadi et al. (2011) investigated the link between 
copper intake and the prevalence of Cu resistance (tcrB) in enterococci in weaned piglets from America. 
They collected a total of 180 faecal samples from two groups of pigs, normal Cu diet (control) and 
elevated Cu diet, at different intervals. The prevalence of tcrB-positive enterococci in the elevated Cu 
group and the control group was 21.1% and 2.8%, respectively. They found a link between the increased 
levels of copper intake and the prevalence of copper-resistant enterococci in piglets. Using a conjugation 
assay, they also reported co-transfer of Cu resistance genes (tcrB) and erythromycin resistance genes 
[erm(B)] between strains of E. faecalis and E. faecium, suggesting potential transferability and co-
selection. The context in which prophylactic and growth-promoting antimicrobials are administered 
creates an ideal environment for the emergence and dissemination of antibiotic-resistant bacteria in 
animals through recurrent exposure to low doses of antimicrobial agents (You & Silbergeld, 2014).  For 
these reasons, the use of antibiotics and heavy metals as growth promoters and feed additives in 
agriculture should be reassessed. 
Wang, et al. (2018) aimed to characterize the origin and distribution of the colistin resistance gene mcr-
1 using a data set of 457 mcr-1-positive sequenced isolates from humans and farm animals from five 
continents by sequencing the genomes of 110 bacterial strains and extracting genomic data from 
publicly available databases. The data was analyzed with novel computational tools that indicated a 
single emergence of mcr-1, dated to the mid-2000s which likely occurred in Chinese pig farms. This 
highlights a single point of origin for colistin resistance gene mcr-1 followed by its subsequent 
diversification between multiple genomic backgrounds during global spread, affecting humans and farm 
animals alike. The authors suggest that possible drivers for the global spread of the ARG are the trade 
of food animals, and meat, as well as global travel of colonized or infected humans. While the ease of 
international travel currently creates an avenue for antibiotic-resistant pathogens to spread globally 
(O’Neill, 2014), the worldwide trade of agricultural products has also contributed to the dissemination 
of bacteria and the spread of ABR with many countries being pressured to intensify agricultural 
production supply to meet export demands. International trade requirements may encourage more 
prudent use of antibiotics in exporting countries; however, importing countries are still at potential risk 
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of importing resistant bacteria, which may be selected for by the resistance-driving chemicals used in 
the exporting country (FAO, 2016; Molechan et al., 2019).  
Two-thirds of the total antibiotics manufactured each year globally are used in animal husbandry 
(Singer et al., 2016). It is estimated that >70% of the antimicrobials consumed in the USA, are in food 
and agriculture production (O’Neill, 2016). In the 2018 European Surveillance of Veterinary 
Antimicrobial Consumption (ESVAC) report, a total of 31 European countries submitted sales data of 
veterinary antimicrobials, expressed as milligrams of antibiotic sold per population correction unit 
(PCU). PCU is a standard unit of measure that considers the number of animals in a country and their 
estimated weight at the time they are likely to be treated with antibiotics, providing an estimate of the 
size of the food-producing animal population in a country. Of the overall veterinary antimicrobial sales, 
the largest amounts were accounted for by tetracyclines (30.7%), penicillins (28.8%), and sulfonamides 
(8.4%), with these three classes accounting for an overall 67.9% of total sales in the 31 countries 
(European Medicines Agency, 2020). A similar trend was observed in the UK, with tetracyclines being 
the most frequently used antibiotic in animals (32%) followed by β-lactams (28%) (Veterinary 
Medicines Directorate, 2019). Between 2011 and 2018, the overall sales of antibiotics for use in animals 
in Europe decreased by approximately 34%. It is of importance to note that there was a decreasing trend 
in the sale of antibiotics considered critically important in human medicine, with third and fourth-
generation cephalosporins, polymyxins, and fluoroquinolones recording a 24%, 70%, and 4% decrease 
in sales between 2011 and 2018, respectively (European Medicines Agency, 2020). Similarly, the UK 
Veterinary Antibiotic Resistance and Sales Surveillance (UK-VARSS) report recorded a 45% 
(56.8mg/kg to 25.8 mg/kg) decrease in the sales of veterinary antibiotics for food-producing animals 
since 2015 in the UK. Overall, in 2019, the total antibiotic sale for use in food-producing animals was 
204 tonnes, which accounted for 26% of the total antibiotic use in the UK. This decreased by 12% since 
2013. Of interest, the antibiotic consumption in humans also dropped by 6% from 2013 to 2017 in the 
UK (Veterinary Medicines Directorate, 2019). These are positive outcomes and indicate that the prudent 
use of antibiotics can be achieved and may in part be due to a One Health approach, which can build 
communication channels across sectors to work together on research and development activities and 
inform experts, policymakers, and legislation. However, the above-mentioned reports do not paint a 
global picture as there can be significant variability in the scale of veterinary antimicrobial use between 
countries. A challenge presents as many countries currently lack the resources for surveillance and data 
collection, and the true estimation of the total annual global consumption of antibiotics in agriculture 
remains elusive (OIE, 2019). 
The impact of AMR on the world’s GDP is estimated at a cumulated cost of over 100 trillion USD by 
2050 (O’Neill, 2016). Van Boeckel et al. (2015) estimated global consumption of antibiotics in food 
animal production at 63,151 (±1,560) tons in 2010. They projected a rise by 67% by 2030, two-thirds 
of which is anticipated to be due to the increasing number of animals raised for food production with 
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use in pig and poultry production expected to double and one-third of which was attributed to intensive 
production systems. China, United States, India, and Brazil account for 50% of total global consumption 
and this would not change in the next ten years. The authors noted that the highest antibiotic 
consumption is in countries that have extensive industrial pig, poultry and cattle systems. These 
projections assume that the way in which antibiotics are used in farms will not change in the future. The 
application of the WHO’s Global Action Plan on Antimicrobial Resistance (WHO, 2015), and the larger 
overall awareness of ABR, may likely reduce the use of antibiotics in the coming years as it is already 
being demonstrated in some countries (Dewulf et al., 2020). A responsible approach to antibiotic 
consumption is necessary to decelerate the rate at which resistance emerges. 
1.2.3 One Health approach 
Antibiotic-resistant bacteria can develop and move between food-producing animals and humans by 
direct exposure or through the food chain and the environment irrespective of geographical or ecological 
borders (FAO, 2016). To better understand the exchange between humans, animals, and the 
environment, it is vital to consider the interaction of elements in the physical environment (e.g., water, 
air, and soil) with communal interactions (e.g., between animals within a herd, farmers and animals), 
in processing (e.g., storage and transport), and human use patterns (e.g., food preparation, meat 
consumption, and susceptibility to infection) (Landers et al. 2012).  
Within the animal agricultural sector, resistant bacteria can emerge from the regular use of antibiotics 
for growth promotion, prophylactic, metaphylactic, and therapeutic purposes in animal production 
systems. As such, the use of antibiotics in animal production systems may present a risk to human health 
as livestock, and their associated environment can act as reservoirs for resistant pathogens. In the human 
health sector, some of the leading drivers of ABR are the use, overuse, misuse, and irrational use of 
antibiotics, easy and/or illegal access to antibiotics, counterfeit antibiotics and poor hygiene practices 
(Mitchell et al., 2020; Kelesidis & Falagas, 2015; Schneider & Ho Tu Nam, 2020). The environment 
can also be contaminated with pharmaceutical waste which is one of the methods by which ARGs can 
transfer among pathogens in the environment (Mitchell et al., 2020). 
 “The One Health approach, defined as ‘...the collaborative effort of multiple disciplines working 
locally, nationally, and globally – to attain optimal health for people, animals, and our environment…’, 
recognizes that human health is closely associated to animal health and the environment” (Robinson et 
al., 2016). ABR is clearly evident in each of these three spheres. The key drivers for antibiotic resistance 
include the scale of antibiotic use in human and animal health sectors; as well as to the relevant 
pathways in which antibiotics enter the environment, namely municipal and industrial wastewater, 
greywater, reclaimed and black water, and land application of manure and sludge.  The drivers of 
AMR/ARGs in the environment include soil-borne resistance, animal husbandry, and wastewater and 
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sludge (Singer et al., 2016). Therefore, AMR is a multisectoral, global problem requiring a One Health 
approach for its control.  
As such, the World Health Organization (WHO), the World Organization for Animal Health (OIE), and 
the Food and Agriculture Organization (FAO) have formed a tripartite alliance and have collectively, 
and individually developed action plans to combat AMR effectively (FAO, 2016; OIE, 2016; WHO, 
2015). In line with the objective to improve AMR awareness and understanding, the FAO/OIE/WHO 
alliance have made efforts in increasing overall awareness and understanding of antimicrobial 
resistance, which include the World Antimicrobial Awareness Week (WAAW) every November and 
the global campaign “Antimicrobials: handle with care” (FAO, 2020; WHO, 2017). Another objective, 
which is to strengthen knowledge through surveillance and research, saw the development of the FAO 
Assessment Tool for Laboratories and AMR Surveillance System (FAO-ATLASS) to aid countries in 
evaluating their national surveillance systems and laboratory diagnostic capacities for AMR detection 
and characterization (FAO, 2020); the WHO launched the Global Antimicrobial Resistance 
Surveillance System (GLASS) which aims to build a picture of resistance patterns worldwide (WHO, 
2015); and the OIE took the lead in creating a global database on antimicrobial use (AMU) in animals 
(OIE Annual Reports on Antimicrobial Agents Intended for Use in Animals) that have been published 
yearly since 2016 (OIE, 2018).  The OIE further developed the OIE Performance of Veterinary Services 
(PVS), a tool for good governance of veterinary services, and the OIE online World Animal Health 
Information System (WAHIS) Interface which provides free access to world animal health data (OIE, 
2019). The latest revisions of the WHO List of Critically Important Antimicrobials (CIA) for Human 
Medicine and the OIE List of Antimicrobial Agents of Veterinary Importance aim to optimize AMU in 
human and animal health (OIE, 2018; WHO, 2019). In 2017, the WHO reported that almost 95% of the 
world’s population live in a country that has or is finalizing its national action plan for antimicrobial 
resistance (WHO, 2017). Countries such as New Zealand, Japan, South Korea, the USA, Canada, Chile, 
and most countries in Europe publish national reports on veterinary antimicrobial use, indicating that 
while significant progress has been made, many countries still lack the surveillance capabilities to 
monitor national antimicrobial usage/ antimicrobial resistance in animals (OIE, 2019).   
1.2.4 Animal food production systems  
There are three main types of animal production systems: land-based extensive systems, land-based 
intensive systems, and organic systems (Robinson et al., 2011). Less intensive farming systems (i.e., 
extensive and organic) are often equated with “sustainable” farming. Land-based extensive farming 
practices may be locally advantageous to the environment (in terms of biodiversity, water, carbon 
storage, or environmental health) but naturally also require low inputs and generate lower agricultural 
yields. These systems may reduce ABR as they require lower levels of antibiotics. 
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The increasing demand for animal-derived food sources among most of the global population has placed 
immense pressure on livestock production systems. The key drivers behind the higher food demand are 
the changes in dietary preferences and population growth, mostly relating to growing affluence and 
urbanization. To meet the global increased demand, there was a shift in farming practices, from 
extensive, small-scale livestock production systems to large-scale, commercially orientated intensive 
farming systems (Robinson et al., 2011). Intensive systems are known to be “land sparing” and farm 
intensively over a small area (Benton et al., 2011) and involve large numbers of animals housed at high 
densities (Robinson et al., 2011). This results in higher agricultural yields however the drawback is that 
the high population density of intensive farming systems results in sharing of both commensal flora and 
pathogens, which can be favorable to the dissemination of infectious bacteria. Intensive environments 
thus necessitate robust infection management strategies that often include antibiotics to keep animals 
healthy and maintain productivity (You & Silbergeld, 2014; Landers et al., 2012). Furthermore, 
intensive farming systems lead to a lack of animal genetic diversity. Considering these points, it is likely 
for populations of antibiotic-resistant bacteria to displace susceptible ones. Hence, it is possible that 
intensive production systems that rely on antibiotics for a lack of biosecurity and good hygiene and 
husbandry practices are faced with the risk of being colonized with resistant pathogens (Molechan et 
al., 2019). 
Brazil, Russia, India, China, and South Africa (BRICS) have adopted intensive production systems, and 
this rapid intensification occurred in order to meet the massive increase in demand. It is estimated that 
over 50% of pigs are raised under intensive systems globally. China accounts for 64% of the intensively 
raised pigs, making China the leading producer of pig meat globally, while high-income countries 
account for 24% of global intensive production (Robinson et al., 2016). Intensive production 
environments generally rely on antibiotics to maintain animal health and productivity. Therefore, the 
BRICS countries are contributing to the rise of ABR (Van Boeckel et al., 2015). 
1.2.5 Biosecurity 
Biosecurity and vaccination are necessary to maintain animal health and thus reduce AMU. External 
biosecurity aims to keep communicable pathogens out of the herd, while internal biosecurity prevents 
the spread of disease within the herd (Backhans et al., 2015). It is critical to prevent and manage animal 
diseases in modern livestock production. Productivity and output on the farm can be decreased by 
outbreaks of disease. This in turn increases treatment costs for the animals. “In modern livestock 
production, the emphasis should be on disease prevention, and only if this fails should antibiotics be 
used” (Dewulf et al., 2020). In a study done by Postma et al. (2015), 111 veterinarian experts ranked 
the most effective alternatives for AMU in pig production. The results showed the top five alternatives 
to AMU to be: “improved biosecurity, increased vaccination, use of zinc/metals, improved feed quality, 
and improved diagnostics” (Dewulf et al., 2020).  
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Improving biosecurity may result in decreasing AMU without threatening productivity. A cross-
sectional study was conducted in 227 pig herds in four European countries between 2012 and 2013, 
where associations between biosecurity, AMU, and production parameters were evaluated. The results 
showed that a higher weaning age, a farrowing rhythm of five weeks or more, and a higher external 
biosecurity level were significantly associated (p <0.05) with lower AMU (Postma et al., 2016; Dewulf 
et al., 2020). In another study, the biosecurity status of breeder-finisher pig herds (n=95) in Belgium 
was quantified using a risk-weighted scoring system. The average external biosecurity score was 65 
(range, 45-89), while the average internal biosecurity score was 52 (range, 18-87). The results showed 
that decreases in disease treatment frequency were associated with higher internal biosecurity scores, 
implying that biosecurity may help in decreasing AMU (Laanen et al., 2013).  
A French study put biosecurity measures into practice in 77 breeder-finisher herds. The results showed 
that there was a difference in profit margins of around €200 per sow per year between high biosecurity 
farms and those with low biosecurity (Corrégé et al., 2012; Dewulf et al., 2020). This shows that higher 
levels of biosecurity also have a cost-benefit. Therefore, improving the biosecurity level should be the 
foundation of any effort to decrease AMU (Dewulf et al., 2020). 
1.2.6 Enterococcus spp. 
Enterococci are Gram-positive, facultatively anaerobic bacteria and commensals in the gut of animals 
and humans.  They may, as such,  provide information on the flow of Gram-positive resistance traits in 
the food chain (Fisher and Phillips, 2009; WHO, 2017). They are opportunistic pathogens and serve as 
reservoirs of resistance genes that can be transferred to human pathogens transiting the intestinal tract 
(Kaye et al., 2004; WHO, 2017). Enterococcus faecalis, E.  faecium, E. hirae, and E. durans, are the 
most prevalent enterococcal species in the microbiota of humans and other mammals. E. casseliflavus, 
E. gallinarum, E. avium, and E. cecorum have also been reported in the microbiota of pigs, although to 
a lesser proportion (Torres et al., 2018). E. faecalis and E.  faecium are two of the most clinically 
important species. (Quiloan et al., 2012). VRE are part of the “ESKAPEE” pathogens, an acronym for 
E. faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas 
aeruginosa, Enterobacter spp., and Escherichia coli, so named for their drug resistance mechanisms 
and ability to evade antibiotics. These bacteria are a common cause of life-threatening nosocomial 
infections amongst critically ill and immunocompromised patients (Santajit and Indrawattana, 2016).  
1.2.7 Critically important “shared” class antimicrobials   
Following the recommendations from two FAO/OIE/WHO expert meetings, The WHO List of CIA for 
Human Medicine and the OIE List of Antimicrobial Agents of Veterinary Importance were initially 
developed. The purpose of the meetings was to address the human health-related consequences 
associated with AMU in food-producing animals. The first meeting convened to discuss this matter, 
recognized that AMR was a global concern for human and animal health and has been impacted by 
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AMU in these sectors, and noted that the classes of antimicrobials used in animals and humans were 
often the same, or structurally related. They further concluded that adverse human health consequences 
resulting from AMU in animals included an increased frequency and/or severity of infections (OIE, 
2018; WHO, 2019). For example, quinolone-resistant Salmonella spp. infections in humans were linked 
to animal sources in Denmark (Hald et al., 2007; WHO, 2019). The consequences of ABR are the most 
severe when pathogens are resistant to CIA for human health. Hence, the overlap of the WHO CIA List 
and the OIE List of Antimicrobials of Veterinary Importance should be considered for risk management 
plans in the human sector, the food animal sector, and in agriculture “through a multisectoral One Health 
approach allowing an appropriate balance between animal health and welfare, and public health” 
(WHO, 2019). 
The criteria used by the OIE to determine the degree of importance for veterinary antibiotic classes 
considered the fact that many different species have to be treated in veterinary medicine. They firstly 
considered the response rate to a questionnaire identifying the importance of the antibiotic class. 
Secondly, antibiotics that treated specific infections and lacked therapeutic alternatives were 
considered.  Antibiotics that met both these criteria were categorized as Veterinary Critically Important 
Antimicrobials (VCIA). The eight VCIA classes include aminoglycosides, third and fourth generation 
cephalosporins, macrolides, penicillins, amphenicols, fluoroquinolones, sulfonamides, and 
tetracyclines, all of which are indicated for use in pigs (OIE, 2018). The WHO CIA List categorized 
antibiotics used in human medicine as critically important, highly important, and important. Antibiotics 
which were deemed of critical importance in human health include five of the VCIA classes excluding 
amphenicols, sulfonamides, and tetracycline. Antibiotics categorized as critically important in human 
health were further prioritized, and those of greatest significance classified as “highest priority CIA”. 
These include quinolones, third and higher generation cephalosporins, macrolides and ketolides, 
glycopeptides, and polymyxins (WHO, 2019). Therefore, the highest priority critically important 
“shared class” antibiotics used in animal and human health include fluoroquinolones and third and 
fourth generation of cephalosporins. In light of this, the OIE recommended that these two classes and 
colistin should not be used as growth promoters, prophylactically or as first-line treatment unless 
justified (OIE, 2018). 
1.2.8 Antibiotic resistance in Enterococcus spp. 
Enterococci have developed resistance to a vast majority of the critically important antibiotics for use 
in humans and animals - these antibiotics include penicillin's, glycopeptides, aminoglycosides, 
quinolones, macrolides, and tetracyclines (OIE, 2018; WHO, 2019). Table 1 lists the antibiotic 
mechanisms of action and resistance in enterococci. 
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Table 1: Antibiotic resistance mechanisms in Enterococci to critically important antibiotics 




Inhibits cell wall synthesis Low binding affinity for ampicillin due to the presence 
of the chromosomal gene, pbp5, which allows 
peptidoglycan synthesis in the presence of β-lactams. 
Drug inactivation mediated by β-lactamase that 











(Arias and Murray, 
2012) 
 
(Miller et al., 2014) 
 




Inhibits cell wall synthesis PBPs (VanA-E) have lower affinities for vancomycin.  
Rare AcrF efflux-mediated resistance has also been 




(Miller et al., 2014) 
(Fair & Tor, 2014) 








Inhibits protein synthesis Intrinsic tolerance due to low uptake and decreased 
binding to ribosomal target 
 
Chromosomally encoded aac(6')-li and aph(3')-IIIa 
result in intrinsic resistance to aminoglycosides except 







(Van Hoek et al., 
2011) 
 






Acquired resistance in E. faecium can be conferred due 
to modification of ribosomal target via efmM (16S 
ribosomal RNA methyltransferase enzyme)  
 
High-level gentamycin resistance is due to modifying 
enzyme aac(6')-le/aph(2”)-la conferring resistance to 


















Inhibits protein synthesis by binding to the 50S 
ribosome 
Resistance arises from modification of 23SrRNA target 














IsaA, mefA, mefE 
msrA, msrC, 
msrD vgaB, vgaC 
 
vatB, vatD, vatE, 
vatG, vgbA 




Tetracyclines Exert antibacterial effect by binding to the 












(Torres et al., 2018) 
 





Interfere with nucleic acid replication, 
transcription, and synthesis 
Capable of acquiring high-level resistance through 
several mechanisms: 
 
Mutation: (gyrA and parC) alter drug binding 
 
Efflux pumps (NorA) has been described in E. faecium. 
 
Target protection by the formation of the quinolone-
gyrase complex, which decreases DNA binding of the 











(Lopez et al., 2011) 
 
 
(Miller et al., 2014) 
 
(Kaye et al., 2004) 







Inhibits protein synthesis Inactivating enzymes cat, catC, 
cat-TC 





Inhibits protein synthesis Mutations of the 23S rRNA binding site 
 
optrA, poxtA,  (Egan et al., 2020) 
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1.2.9 Virulence factors  
There are a variety of genes encoding virulence factors in Enterococcus spp. which include aggregation 
substance (asa1), cell adhesins (efaAfs, efaAfm), enterococcal surface protein (esp), hyaluronidase (hyl), 
sex pheromones (cpd, cob, ccf, and cad) and secreted factors such as gelatinase (gelE) and cytolysin 
(cylA). Cytolysin (cylA and cylB) is encoded on pheromone-responsive plasmids and has haemolytic 
and bactericidal activity, while gelatinase (gelE) mediates virulence by activating autolysin and biofilm 
formation. Cell surface determinants such as aggregation substance (asa1) contribute to virulence by 
facilitating aggregation of donor and recipient bacteria for high-frequency transfer of plasmid DNA. 
Another cell surface determinant, the enterococcal surface protein encoded by the esp gene, affects 
biofilm formation. Hyaluronidase (hyl) is a degradative enzyme that acts on hyaluronic acid and is 
associated with tissue damage (Upadhyaya et al., 2011; Fisher and Phillips, 2009; Arias and Murray, 
2012; Biswas et al., 2016; Kayaoglu and Ørstavik, 2004).  
1.2.10 Dissemination of antibiotic resistance and virulence genes 
Bacterial genomes comprise chromosomal DNA and accessory genetic elements such as gene cassettes, 
integrons, insertion sequence common regions, integrative and conjugative elements (ICEs), plasmids, 
and transposons. While chromosomal DNA encodes genetic information to control the life cycle of the 
bacterium, accessory genetic elements confer survival advantages, such as antibiotic resistance 
(Molechan et al., 2019). ABR can be inherited intrinsically or via acquired resistance. Intrinsic 
resistance is shared by all bacteria of the same genus or species as it is located within the genome of the 
bacterial species.  Mutations of intrinsic genes, or vertical transmission, occur in the chromosomal genes 
which are then inherited by the bacterial progeny and can often alter gene expression. Acquired 
resistance allows bacteria to acquire new genetic material via horizontal gene transfer (HGT) or through 
sporadic mutations of intrinsic genes (Singer et al., 2016).   
A primary mechanism for acquired resistance is via HGT and involves mobile genetic elements 
(MGEs), which “refer to elements that promote intracellular DNA mobility (e.g., from the chromosome 
to a plasmid or between plasmids) as well as those that enable intercellular DNA mobility” (Partridge 
et al., 2018). Intracellular MGEs include transposons, insertion sequences (ISs), and integrons. 
Transposons and ISs are short portions of DNA “that are able to move themselves (and associated 
resistance genes) to new locations” within a genome. Integrons use “site-specific recombination to 
move resistance genes between defined sites” (Partridge et al., 2018).  The mechanisms that enable 
intercellular DNA mobility include (1) transformation, (2) transduction, and (3) conjugation. 
Transformation involves the uptake of naked DNA from the environment. Transduction is where a 
bacteriophage acts as a vector transporting DNA from one bacterial cell to another (Van Hoek et al., 
2011). Conjugation involves the transfer of DNA through direct contact between two bacteria (mediated 
by plasmids and ICEs) (Wozniak and Waldor, 2010).  Conjugative transmission is uninhibited in that 
they can transfer to other species or genera (von Wintersdorff et al., 2016). It is the numerous 
15 
 
interactions between various types of MGEs that allow antibiotic resistance and virulence determinants 
to mobilize and transfer between cells and that promote the rapid evolution of diverse multidrug-
resistant pathogens (Partridge et al., 2018; Singer et al., 2016).  
1.2.11 Mobile genetic elements 
ARGs are often located on a conjugative or mobilizable element that is most often a plasmid or 
transposon. In Enterococcus spp., antibiotic resistance has disseminated due to their ability to transfer 
resistant and virulent genes via conjugative plasmids and conjugative transposons (von Wintersdorff et 
al., 2016). Plasmids can be found in almost all bacterial genera and are described as extrachromosomal 
DNA elements which contain an origin of replication and genes encoding replication functions making 
them capable of autonomous replication. However, plasmids can also contain genes that encode 
functions to allow them to transfer via conjugation. “Plasmids that harbor conjugation genes are called 
conjugative and plasmids that only contain an origin of transfer (oriT), but no conjugation genes are 
called mobilizable as they can make use of the conjugation functions of conjugative plasmids to transfer 
to a new host” (Van Hoek et al., 2011). Additionally, plasmids encode antibiotic resistance genes 
resistance which can be located on a conjugative or mobilizable plasmid giving them the capability to 
transfer to new hosts. Plasmids may be grouped as “narrow” or “broad host range” where a narrow host 
range is confined to one bacterial species and a broad host range can transfer between different species 
(Van Hoek et al., 2011).  
Of the “narrow host range” plasmids, pheromone-responsive plasmids represent a unique group of 
conjugative plasmids. pAD1, pAM373, and pCF10 are the best characterized pheromone-responsive 
plasmids in enterococci.  The conjugative mechanism of these plasmids is based on sex pheromones 
(extracellular peptides), which are produced by pheromone-responsive donor cells, thereby producing 
cell aggregation substances (AS) on the cell surface, which facilitates conjugation and DNA transfer 
(Hegstad et al., 2010). Pheromone-responsive plasmids have been mostly associated with E. faecalis 
(Wardal et al., 2010). Antibiotic resistance determinants are also located on these plasmids. 
Vancomycin resistance genes (vanA and vanB) have been located on pheromone-responsive plasmids, 
with vanA being described in E. faecalis and E. faecium while vanB was described in E. faecalis only 
(Wardal et al., 2010). Virulence factors, such a AS and cytolysin, which contribute to rapid DNA 
transfer and haemolytic activity respectively, are also located on these plasmids. Hence, pheromone-
responsive plasmids often contain both antibiotic resistance and virulence determinants.   
 
Another class of enterococcal plasmids that play a role in the spread of ARGs include the “broad host 
range plasmids”, also known as incompatibility plasmids (Inc18). One of the best characterized 
conjugative Inc18 plasmids in Streptococcus and Enterococcus spp. is pIP501. Inc18 plasmids can 
encode resistance to a variety of antibiotics, including chloramphenicol, vancomycin, and MLS groups 
of antibiotics, which can be transferred to other species. These plasmids were found to be responsible 
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for the transfer of vancomycin resistance (encoded by vanA gene) from VRE to methicillin-resistant 
Staphylococcus aureus (MRSA) (Kohler et al., 2018). Recently, the presence of oxazolidinone 
resistance gene poxtA located on Inc18 plasmids (pC25-1 and pC27-2) from CC17 E. faecium of pig 
origin was described in China (Huang et al., 2019). Therefore, HGT has allowed antibiotic resistance 
and virulence traits to disseminate, and this presents a challenge to treatment options when bacterial 
strains possess acquired resistance to last-line antibiotics. 
A variety of transposons have been described in enterococci as they can encode antimicrobial resistance 
determinants, virulence factors and facilitate ease of transfer. There are three main categories in which 
enterococcal transposons can be grouped, namely, composite transposons, Tn3 family transposons, and 
conjugative transposons (Hegstad et al., 2010). Composite transposons have been associated with high-
level gentamicin resistance (HLGR) and glycopeptide resistance (vanB1-type) in enterococci. They are 
mobilized by flanking copies of ISs, which are identical sequences that move the DNA. The Tn3 family 
of transposons move amid different replicons via a replicative mechanism. They have been known to 
mediate glycopeptide (vanA-type) and macrolide-lincosamide-streptogramin B (MLSB) resistance in 
enterococci. Conjugative transposons, also known as ICE, encode all the information necessary for their 
own excision, conjugation, and integration into a new host and have been known to mediate resistance 
to tetracyclines, MLS-antibiotics, and glycopeptide resistance (vanB2- type) in enterococci. 
Conjugative transposons can transfer between a broad host range, possibly carrying clinically relevant 
resistance determinants between a more extensive bacterial diversity. Members of the Tn916/Tn1545-
family are the most relevant (Hegstad et al., 2010). 
1.2.12 Prevalence of ABR in Enterococcus spp. 
Animals in food production have frequently been reported as reservoirs for the dissemination of 
resistance genes in humans. (Vignaroli et al., 2011; Hammerum, 2012). Enterococci are commensals 
of the intestinal tract in animals and humans. In practice, AMU in animals is alleged to be the main 
driver for ABR development in animal bacteria. However, there is also evidence for transmission of 
resistance- determinants from animals to humans and vice versa (Crombé et al., 2013; Madec et al., 
2017; Dewulf et al., 2019). While the risk of zoonotic disease is rare, more awareness needs to be drawn 
to the fact that ABR strains may act as a reservoir of resistance determinants for bacteria in the intestinal 
tract. Of a review of 139 academic research articles that address the issue of antibiotic use in agriculture, 
72% (n=100) found evidence of a link between antibiotic consumption in animals and resistance in 
humans. In contrast, only 5% (n=7) argued that there was no link and 23% (n=32) did not take explicitly 
take a stance (O’Neill, 2016). Antibiotic resistance determinants have the uninhibited potential to be 
transferred to other species or genera, and the use of CIA in food animals has implications for human 
health, as well as animal health and food security since this can create the setting for the emergence of 
new MDR pathogenic strains.  
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The following study shows some evidence for a spillover of ABR enterococci from animals to humans 
and vice versa:  Freitas et al. (2011) compared the clonal relatedness of VRE in pigs and humans. They 
compared VRE isolates from pigs (n=29) and healthy humans (n=12) collected from Portugal, 
Denmark, Spain, Switzerland, and the United States (1995 to 2008) against clinical VRE isolates (140 
E. faecium and 50 E. faecalis) recovered from 23 counties, during the last 3 decades. Clonal relatedness 
was determined using pulse-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST) 
typing methods. The authors found thirty clonally related E. faecium clonal complex 5 (CC5) isolates 
which were obtained from the faeces of pigs and humans. E. faecium CC17 isolates from pig manure 
(n=1), and healthy human faecal samples (n=5) showed identical PFGE patterns while one E. faecalis 
CC2 isolate obtained from pigs corresponded to MDR clones widely disseminated in hospitals in Italy, 
Portugal, and Spain. Human-adapted clonal complexes included E. faecium CC17 and E. faecalis CC2, 
both of which were found in pigs in this study while animal-adapted strains include E. faecium CC5 
was also found in humans. Hence, the authors concluded that enterococcal clones belonging to host-
adapted clonal complexes of E. faecium and E. faecalis could be shared by pigs and humans. 
In the United States, Donabedian et al. (2010) aimed to characterize VRE. faecium isolated from human 
and animal origin. A total of 360 faecal specimens were obtained from humans and their animals (55 
samples from pigs) being raised for an exhibit at three county fairs in Michigan in 2008. VRE. faecium 
was isolated in 6 pigs but was not present in humans or other animals. The PFGE patterns and MLST 
of the six isolates were found to be similar with sequence types belonging to CC5, which is an animal-
adapted CC. This could indicate the dissemination of VRE. faecium strains among pigs. This highlights 
the possibility of dissemination of ABR enterococci between animals. 
A study by Metiner et al. (2013) obtained 47 enterococci isolates from 69 faecal samples on three pig 
farms in Turkey in 2003 and determined their antibiotic susceptibilities. A large majority of the isolates 
were identified as E. faecium (68%), followed by E. faecalis (21.7%). Erythromycin resistance in E. 
faecium and E. faecalis was 93.6% and 100%, respectively. Vancomycin resistance and intermediate 
resistance were observed in eight isolates for E. faecium and nine isolates for E. faecalis.  
A study conducted in Thailand aimed to isolate, identify, and characterize antibiotic susceptibilities of 
VRE from pig farms. A total of 179 faecal samples were collected from four pig farms in 2011. There 
was an overall prevalence of 24% (n=43) of VRE in pigs. Of 71 presumptive VRE isolates detected, E. 
gallinarum isolates (62%, n=44) were the most prominent, followed by E. casseliflavus (35%, n=25). 
All isolates were susceptible to teicoplanin, whereas a large number of isolates showed resistance to 
tetracyclines (86.5%), erythromycin (61.5%), and penicillins (53.8%) (Pruksakorn et al., 2016). This 
highlights the presence of antibiotic-resistant enterococci among pigs in food production.  
Furthermore, in a study conducted by Braga and Lopez (2013), environmental dust from pig breeding 
facilities (n=171) in Portugal was screened for enterococci and VRE in 2008. Enterococcus spp. was 
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present in 150 facilities (88%) of which, was a 15% prevalence of VRE. MLST typing showed that four 
VRE. faecium isolates carrying the vanA genotype were closely related to pig and human isolates from 
European countries and Brazil. Generally, the species found in dust were similarly found in other 
environments related to pigs and pig facilities such as faeces, manure, meat, soil, and wastewater. This 
shows that there are incidences of ABR enterococci that have been isolated from the associated 
environments of pigs in food production. 
In South Africa, a study to determine the prevalence of species distribution, antibiotic resistance, and 
virulence of Enterococcus spp. isolated from pigs. 320 Enterococcus spp. isolates were collected from 
two pig farms in the Eastern Cape. Molecular screening confirmed 37.5% of the isolates as E. faecium, 
31.25% E. hirae, 18.75% followed by 12.5% E. faecalis. The results indicated a high prevalence of 
multi-drug resistant isolates (93.8%) as well as high levels of vancomycin-resistance (100%). The most 
common virulence factors that were detected included: ace (96.88%), gelE (93.13%), and esp (67.8%) 
(Iweriebor et al., 2015). The high prevalence of VRE and MDR enterococci in this study agreed with 
the understanding that to fully appreciate the complexity of Enterococcus species in causing disease, a 
greater understanding of the ability of Enterococcus species to survive stresses, its virulence traits, and 
antibiotic resistance, is needed as Enterococcus spp. from pigs could be reservoirs of antibiotic 
resistance and virulence genes. 
1.3 Aim 
 To investigate the molecular epidemiology of antibiotic-resistant Enterococcus spp., from farm-to-
fork, in an intensive pig production system in uMgungundlovu district, Kwa-Zulu Natal. 
1.4 Objectives 
• To enumerate and culture Enterococcus spp., using Enterolert® and selective media, across the 
food production chain from the following sources: faecal and wastewater samples at the farm 
(bi-monthly), trucks, caecal samples, carcass swabs, and carcass rinsate collected post-slaughter 
as well as retail meat products.   
• To genotypically confirm and speciate Enterococcus spp. using real-time polymerase chain 
reaction (RT-PCR) for the detection of the genus and species-specific genes. 
• To determine the antibiotic susceptibility of isolates against a panel of antibiotics, 
recommended by WHO-AGISAR, using Kirby-Bauer disk diffusion according to European 
Committee on Antimicrobial Susceptibility Testing (EUCAST) guidelines. 
• To detect the presence of selected antibiotic resistance genes in isolates displaying phenotypic 
antibiotic resistance via RT-PCR, viz., tetK, tetM, ermB, aac(6’)-le-aph(2’’)-la and aph(3’-llla. 
• To detect the presence of selected virulence genes, viz., gelE, cpd, cylA, cylB, efaAfs, efaAfm 
in isolated enterococci via RT-PCR 
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• To elucidate the clonal relatedness of isolates by repetitive element palindromic PCR (REP-
PCR)  
 
1.5 Summary of methodology 
The WHO-AGISAR guidelines (WHO, 2017) were implemented for the sampling strategy. The 
sampling points that were included as part of the farm-to-fork continuum are as follows: growth period 
on the farm (fresh pig faeces and wastewater/slurry), transport (truck), abattoir (carcass swabs, carcass 
rinsate, and caeca), retail meat (body, head, and thigh). Molecular confirmation by RT-PCR, targeting 
the genus- (tuf) and species-specific (sodA) genes, was undertaken. Susceptibility profiles were assessed 
by Kirby-Bauer disk diffusion using the WHO-AGISAR recommended panel of antibiotics for 
Enterococcus spp. Antibiotic resistance and virulence genes were detected using RT-PCR. Genetic 
relatedness between isolates across the continuum was evaluated by REP-PCR. 
 
1.6 Study outline 
The research findings are presented in three chapters as follows: 
  
Chapter 1 provides the background, literature review, rationale for the study as well as the aims and 
objectives. 
  
Chapter 2 provides information about the investigations undertaken and the findings and is presented 
in the form of a manuscript prepared for Science of the Total Environment 
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Background: Substantial antibiotic use and high population densities in intensive farming systems 
results in the emergence and spread of antibiotic-resistant commensals and pathogens. This study 
investigated the molecular epidemiology of antibiotic resistance (ABR) and virulence in Enterococcus 
spp. from pigs in an intensive food production continuum from farm-to-fork in the uMgungundlovu 
district, Kwa-Zulu Natal.  
 
Methods: A total of 174 samples obtained along the pig farm-to-fork continuum (farm, transport, 
abattoir, and retail meat) were subjected to the quantification and putative identification of 
Enterococcus spp. using the IDEXX Enterolert® method and selective media, respectively. Up to three 
presumptive enterococcal colonies were picked per sampling point for molecular confirmation by real-
time PCR, targeting the genus- and species-specific (tuf and sodA) genes, respectively. Antibiotic 
resistance profiles were determined by the Kirby-Bauer disk diffusion method against a panel of 
antibiotics for Enterococcus spp. recommended by the WHO-AGISAR using EUCAST guidelines. 
Selected antibiotic resistance and virulence genes were detected by real-time PCR. Clonal relatedness 
between isolates across the continuum was evaluated by REP-PCR. 
 
Results: A total of 284 isolates constituted the final sample. Real-time PCR confirmed 79.2% of the 
isolates as E. faecalis, 6.7% as E. faecium, 2.5% as E. casseliflavus, 0.4% as E. gallinarum, and 11.2% 
as other Enterococcus spp. Antibiotic susceptibility testing revealed resistance to sulfamethoxazole-
trimethoprim (78.8%), tetracycline (76.9%), erythromycin (68.1%), streptomycin (62.6%), 
chloramphenicol (27.0%), ciprofloxacin (8.5%), gentamicin (8.1%), and levofloxacin (5.6%) but no 
vancomycin, teicoplanin, tigecycline or linezolid resistance was detected. E. faecium displayed 44.4% 
resistance to quinupristin-dalfopristin. A total of 78% of enterococcal isolates were MDR. Phenotypic 
resistance to tetracycline, aminoglycosides, and macrolides was corroborated by the presence of the 
tetM, aph(3’)-IIIa, and ermB genes in 99.1%, 96.1%, and 88.3% of the isolates, respectively. The most 
commonly detected virulence genes were: gelE, efaAfs, and cpd in 89.1%, 78.5%, and 77.1% of isolates 
conferring autolysin and biofilm formation capabilities, cell adhesion, and conjugative plasmid 
accumulation, respectively. Clonality evaluated by REP-PCR revealed that E. faecalis isolates belonged 
to diverse clones along the continuum with major REP-types, largely consisting of isolates from the 
same sampling source but different sampling rounds (on the farm). E. faecium isolates revealed a less 
diverse profile.  There was minimal evidence of clonal transmission across the continuum.   
 
Conclusion: Multi-drug resistant Enterococcus spp. were isolated in this study. Isolates harboured a 
diversity of antibiotic resistance and virulence genes in different combinations forming reservoirs for 
the potential transfer of these genes from pigs to occupationally exposed workers and consumers via 
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direct contact with animals and animal products/food, respectively. The results highlight the need for 
more robust guidelines for antibiotic use in intensive farming practices and the necessity of including 




Antibiotic resistance (ABR) occurs naturally but has been exacerbated by the inappropriate and 
excessive use of antibiotics, poor therapy adherence, over-use of antibiotics in food-producing animals, 
and poor hygiene and sanitation (FAO, 2016). A direct consequence of ABR is the failure to 
successfully treat infections, which leads to increased mortality, prolonged illness, and reduced 
livelihood and food security. With the rise in ABR and a decline in new antibiotic discovery and 
development, it is imperative to monitor the emergence and spread of ABR in humans and (food) 
animals.  
Antibiotic resistant bacteria can develop and move between food-producing animals and humans by 
direct exposure or through the food chain and the environment irrespective of geographical or ecological 
borders (FAO, 2016). There is a shift in farming practices, with a larger proportion of animals projected 
to be raised in cost-effective intensive farming systems where  the high population densities and sub-
optimal vaccination, biosecurity and animal husbandry practices results in the over-reliance on the use 
of antibiotics for the prophylactic and metaphylactic management of infections that subsequently results 
in the emergence and spread of antibiotic-resistant commensals and pathogens (You & Silbergeld, 2014; 
Landers et al., 2012 ).Global consumption of antibiotics in food animal production is projected to rise 
by 67% by 2030, two-thirds of which is expected to be used in intensive food animal production with 
use in pig and poultry production expected to double. (Van Boeckel et al., 2015).  
Enterococci are Gram-positive bacteria and commensals in the gut of animals and humans, and as such, 
they provide information on the flow of Gram-positive resistance traits in the food chain (Fisher and 
Phillips, 2009; WHO, 2017). They are opportunistic pathogens and serve as reservoirs of resistance 
genes that can be transferred to human pathogens transiting the intestinal tract (Kaye et al., 2004; WHO, 
2017). E. faecalis, E. faecium, E. hirae, and E. durans, are the most prevalent enterococcal species in 
the microbiota of humans and other mammals. E. casseliflavus, E. gallinarum, E. avium, and E. cecorum 
have also been reported in the microbiota of pigs, although in a lesser proportion (Torres et al., 2018). 
E.  faecalis and E. faecium are two of the most clinically important species (Quiloan et al., 2012). 
The pathogenicity of Enterococcus spp. has been enhanced by the expression of various virulence and 
antibiotic resistance genes that have been mobilized on diverse mobile genetic elements and are 
transferred by horizontal gene transfer (HGT). There is a deficit of data on the molecular characteristics 
of antibiotic-resistant enterococci in pigs along the farm-to-fork continuum in South Africa. This study 
investigated the molecular epidemiology of antibiotic-resistant Enterococcus spp. from pigs in the food 





2.1 Ethical Clearance  
Ethical approval was obtained from the Animal Research Ethics Committee (Reference: 
AREC/007/018) and the Biomedical Research Ethics Committee (Reference: BCA444/16) of the 
University of KwaZulu-Natal (Appendix 1 & 2, respectively). This study also received permission to 
undertake this research in terms of Section 20A of the Animal Diseases Act, 1984 (Act no. 35 of 1984) 
from The South African National Department of Agriculture, Forestry and Fisheries (Reference: 
12/11/1/5; Appendix 3). 
2.2 Study population and sampling strategy  
The study was conducted over 4 months (September 2018- January 2019) at an intensive pig farm and 
its associated abattoir in the uMgungundlovu District of Kwa-Zulu Natal, South Africa. The 
implementation of the sampling strategy was done as recommended by the WHO-AGISAR guidelines 
(WHO, 2017) The sampling points that were included as part of the farm-to-fork continuum are as 
follows: growth period on the farm (fresh pig faeces and wastewater), transport (truck), abattoir (carcass 
swabs, carcass rinsate, and caeca), retail meat (body, head, and thigh).    
Random sampling was implemented, and a single litter of piglets was selected as the sample population. 
Sampling was conducted twice weekly over a 4-month period on the farm, which resulted in 9 sampling 
points. Fresh faecal samples were collected using the block sampling method to ensure that they were 
representative of the entire herd. Wastewater was collected from two associated drainage pipes. After 
the growth phase on the farm, the pigs were transported via trucks to the abattoir for slaughter, during 
which time, swabs of the truck before and after the pigs were loaded were collected. At the abattoir, 
carcass swabs, caecal content, and carcass rinsates were collected post-slaughter. Swabs of retail meat 
from the body, head, and thigh portions were obtained from the abattoir the next day. The sampling 
framework is summarized in Table 1. 
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Samples were transported to the laboratory on ice and processed within 6 hours after collection. 
2.3 Isolation and identification of Enterococcus spp. 
The collected samples were diluted 1:10 in sterilized distilled water and vortexed. The samples were 
then processed using the IDEXX Enterolert® (IDEXX Laboratories, Inc., Westbrook, Maine, U.S.A) 
method according to manufacturer. The following quantities of each sample were used for the 
Enterolert® method: 100µL of faecal samples, 10µL of wastewater samples, 1ml of truck samples, 1ml 
of carcass rinsate, 20µL of caecal content, 1ml of carcass swabs, and 1ml of body, head and thigh 
samples, all of which were mixed with 100ml of sterilized water, respectively. The Enterolert® reagent 
was added to each 100ml bottle and poured into a Quanti-Tray®/2000 and sealed with a Quanti-Tray 
sealer PLUS. Each Quanti-Tray was incubated for 24h at 41°C, to enrich for enterococci. After 24 
h, each Quanti-Tray was viewed under ultraviolet light, and fluorescent wells were presumed positive 
for enterococci. The samples from fluorescence-positive wells were then inoculated onto selective 
Chromocult® enterococci agar (Merck, Darmstadt, Germany) and incubated for 24 h at 37°C. Red 
colonies were positive for Enterococcus spp. while non-enterococci produced colourless, blue or 
turquoise colonies. Individual colonies were then picked and inoculated onto bile-esculin agar (Lab M, 
Lancashire, UK), and incubated for 24h at 37°C. Observation of dark brown colonies were deemed 
positive for enterococci. Single colonies were inoculated onto tryptone soya agar (TSA) (Oxoid, 
Hampshire, England) and further incubated for 24 h at 37 °C. Colonies that were presumed to be 
enterococci were stored in a 20% glycerol stock solution at -80°C for future use. Enterococcus faecalis 
ATCC 29212 was used as the control strain (EUCAST, 2017). 
 
2.4 Molecular confirmation and speciation of Enterococcus  
The heat lysis method was used to extract DNA as previously described (Molechan et al. 2019). Briefly, 
after an initial resuscitation on nutrient agar, 3-6 colonies were picked and mixed into nuclease-free 
water in sterile Eppendorf tubes. They were then vortexed to produce a turbid suspension and boiled in 
a water-bath for 10 min followed by centrifuging. The supernatant was extracted and stored at -20° C 
for further use.   
 
The extracted DNA (3 µL) was used as the template in a 10-µL reaction volume made up of 5 µL 
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sets of 5 
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each forward and reverse primers (final concentration, 0.5 µM), and 1 µl of nuclease-free water. The 
positive controls, oligonucleotide primer pairs, thermal cycling conditions and melt-curve analysis were 
as previously described by Molechan et al. (2019), with minor modifications on the initial activation in 
the cycling conditions for the detection of the Enterococcus genus. Here, the initial activation consisted 
of an initial incubation at 50° C for 2 min, followed by a second one at 95° C for 2 min.  
 
Similarly, real-time PCR was used for speciation of E. faecalis, E. faecium, E. gallinarum, E. 
casseliflavus. The reactions were carried out in a total volume of 10 µl with Luna® Universal qPCR 
master mix (New England Biolabs, Ipswich, MA, USA) replacing the PowerUp™ SYBR™ Green 
master mix. The positive controls, oligonucleotide primer pairs, thermal cycling conditions and melt-
curve analysis were as previously described by Molechan et al. (2019), with a minor increase in the 
number of cycles from 30 to 35. A QuantStudio™ 5 Real-Time PCR System (ThermoFisher Scientific, 
Waltham, MA, USA) was used to carry out all reactions. A positive control and a No Template Control 
(NTC) -consisting of the PCR mix and nuclease-free water instead of template DNA was included in 
each assay. The positive controls, oligonucleotide primer pairs, and amplicon sizes are shown in Table 
S1. 
2.6 Antimicrobial susceptibility testing 
The Kirby-Bauer disc diffusion method was used to test antibiotic susceptibility. The antibiotic panel 
recommended by WHO-AGISAR (WHO, 2017) using European Committee on Antimicrobial 
Susceptibility Testing (EUCAST, 2017) guidelines were used. The Clinical and Laboratory Standards 
Institute (CLSI, 2017) recommendations were used for those antibiotic breakpoints absent from the 
EUCAST guidelines. The following antibiotics were used:  ampicillin (10ug), imipenem (10ug), 
ciprofloxacin (15ug), levofloxacin (15ug), gentamicin (120ug), streptomycin (300ug), teicoplanin 
(30ug), vancomycin (30ug), quinupristin-dalfopristin (15ug) (E. faecium only), tigecycline (15ug), 
linezolid (30ug), nitrofurantoin (300ug), sulfamethoxazole-trimethoprim (25ug), erythromycin (15ug), 
tetracycline (30ug) and chloramphenicol (30ug). The antibiotics were purchased from Oxoid 
(Basingstoke, United Kingdom). Isolates resistant to one or more antibiotics in at least three distinct 
classes of antibiotics were defined as multidrug-resistant (MDR). MDR isolates were selected for 
further analysis based on their source and resistance profiles. 
2.7 Molecular detection of antibiotic resistance and virulence genes 
A real-time PCR assay was used to detect antibiotic resistance and virulence genes. The reaction 
concentrations, reagents, total volume, and PCR assay parameters followed were previously described 
by Molechan et al. (2019). All genes were amplified in separate assays and the positive controls, 





The clonal distribution among selected MDR E. faecalis isolates (n=99) and all E. faecium isolates 
(n=19) were characterized with repetitive extragenic palindromic-PCR (REP-PCR) using the (GTG)5 
primer as described by Molechan et al. (2019). Briefly, GeneJET Genomic DNA purification kit 
(ThermoFisher Scientific, Waltham, MA, USA) was used to extract DNA according to the 
manufacturer’s guidelines. Thereafter, amplification was carried out in a 25 µl reaction volume. 
Amplicons were then electrophoresed in agarose gel and the gels were visualized using the Gel Doc™ 
XR+ imaging system (Bio-Rad, Hercules, California, USA) while the Bionumerics software version 
6.6 (Applied Maths NV, Belgium) was used to analyze the images (Appendix 4). Clusters were 
obtained at a ≥70.0% similarity cut-off. 
 
Results 
1. Prevalence of Enterococcus spp.  
A total of 284 isolates were obtained along the farm-to-fork continuum of which, 145 (51.1%), 44 
(15.5%), 39 (13.7%), and 56 (19.7%) were obtained from the farm, transport, abattoir, and retail 
sampling points, respectively. Of the 284, 225 (79.2%) were E. faecalis, 19 (6.7%) were E. faecium, 7 
(2.5%) were E. casseliflavus, 1 (0.4%) were E. gallinarum, while 32 (11.2%) were classified as “other 
Enterococcus spp.” (Figure 1). The E. faecalis isolates were most prevalent throughout the continuum, 
while E. faecium isolates were obtained mainly at the farm level (Round 1, 2, and 6). No E. faecium 
isolates were recovered from transport or retail sampling points. There was a low prevalence of E. 
casseliflavus and E. gallinarum, with a few isolates being identified from the farm (Round 1 and 9) and 
transport vehicles.   
2. Antibiotic resistance 
AST results showed 100% susceptibility to ampicillin, imipenem, teicoplanin, vancomycin and 
linezolid while resistance to sulfamethoxazole-trimethoprim (78.8%), tetracycline (76.9%), 
erythromycin (68.1%), streptomycin (62.6%), chloramphenicol (27.0%), ciprofloxacin (8.5%), 
gentamicin (8.1%), and levofloxacin (5,6%) was observed. Furthermore, 44.4% of E. faecium isolates 
exhibited resistance to quinupristin-dalfopristin (Quinupristin-dalfopristin is only clinically relevant for 
E. faecium hence antibiotic susceptibility is only reported for this species) (Table 2).  
Figure 2 depicts the resistance profiles of the Enterococcus isolates along the farm-to-fork continuum. 
Streptomycin, erythromycin, and tetracycline (>75%) displayed the highest rates of resistance in 
isolates from the farm level. E. faecalis displayed the highest resistance to tetracycline (80%), followed 
by sulfamethoxazole-trimethoprim (78%), erythromycin (72%), streptomycin (70%), chloramphenicol 
(25%), gentamicin (15%), ciprofloxacin (9%), levofloxacin (4%), and nitrofurantoin (3%).  
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Among all the isolates, 222 (78%) were multidrug-resistant (MDR) with a total of 47 antibiograms 
being identified. Of the MDR isolates, 176 (79.3%) were E. faecalis, 13 (5.9%) were E. faecium, 5 
(2.3%) were E. casseliflavus, 1 (0.5%) was E. gallinarum, and 27 (12.1%) were ‘other’ Enterococcus 
spp. E. faecalis showed 38 antibiograms while E. faecium, E. casseliflavus, E. gallinarum, and the other 
Enterococcus spp.  showed eight, four, one, and nine antibiograms, respectively (Table 3).  
3. Prevalence of antibiotic resistance genes 
Phenotypic resistance to tetracycline, aminoglycosides, and macrolides was corroborated by the 
presence of the tetM, aph(3’)-IIIa, and ermB genes in 99.1%, 96.1%, and 88.3% of the isolates, 
respectively. E. faecalis displayed the highest occurrence of resistance genes compared to the other 
enterococcal species with the following distribution: tetM (77.6%), aph(3’)-IIIa (76.0%), ermB 
(67.8%), tetK (15.4%), and aac(6')-Ie-aph(2")-Ia (5.1%). The ermB gene was detected in each species 
with the prevalence in descending order as follows: E. faecalis (67.8%), Enterococcus spp. (12.7%), E. 
faecium (6.3%), E. casseliflavus (1.0%), and E. gallinarum (0.5%). Tetracycline resistance was 
associated to a larger extent with the presence of tetM (99.1%) than with tetK (17.1%). Gentamicin 
resistance, associated with the gene aac(6’)-Ie-aph(2”)-Ia, was only detected in two E. faecalis isolates. 
The aph(3’)-IIIa gene was present in 96.1% of isolates with high-level resistance to streptomycin and 
was more commonly detected in E. faecalis isolates (76.0%), followed by Enterococcus spp. (12.7%), 
E. faecium (5.4%), and E. casseliflavus (2.0%). The one E. gallinarum isolate showed the presence of 
ermB and tetM (Table 4). 
4. Detection of virulence of factors 
In all the enterococcal isolates, the frequency of virulence genes was as follows: gelE (89.1%), efaAfs 
(78.5%), cpd (77.1%), cylB (31.3%), cylA (18.3%), and efaAfm (3.5%). E. faecalis displayed the highest 
occurrence of virulence genes compared to the other enterococcal species with the allocation as follows: 
gelE (92.4%), efaAfs (89.3%), cpd (82.7%), cylB (35.6%), and cylA (21.8%). gelE was the most 
dominant gene detected among E. faecium, E. casseliflavus and Enterococcus spp. isolates at 68.4%, 
71.4%, and 84.4%, respectively.  
 The prevalence of virulence factors detected in all enterococcal isolates were as follows: gelE (89.1%), 
efaAfs (78.5%), cpd (77.1%), cylB (31.3%), cylA (18.3%), and efaAfm (3.5%). The most prevalent 
virulence gene detected among E. casseliflavus, E. faecium, and Enterococcus spp. isolates was gelE 
with a frequency of 71.4%, 68.4%, and 84.4%, respectively.  Only 9 E. faecium isolates (47.4%) tested 
positive for efaAfm while E. gallinarum had no virulence genes detected (Table 5).   
5. Clonal Relatedness  
The evolutionary relationships of selected MDR E. faecalis isolates (n=99) and all E. faecium isolates 
(n=19) were determined using REP-PCR (Figure 3 and Figure 4, respectively). The E. faecalis isolates 
38 
 
were chosen based on their antibiograms and source of isolation such that isolates with the same 
antibiogram from each sampling point were represented. E. faecalis displayed 35 REP-types (A-AI). 
There were 6 major REP-types which consisted of 47.5% (n=47) of E. faecalis isolates namely: type U 
(n=9), type AI (n=9), type T (n=8), type Z (n=7), type Q (n=7), and type AH (n=7). E. faecalis isolates 
from the “farm” were represented in all major REP-types. However, it must be noted that they were 
from different rounds of sampling on the farm (Round 1- Round 8). E. faecalis isolates from “transport” 
were also represented in major REP-type AI, while isolates from the “abattoir” and “retail” were quite 
diverse with representation in REP-types AH, T, Z, X and AD in the former and REP-types K, N, Q, T, 
U, V and Z in the latter. E. faecium displayed 7 REP-types (A-G). There were 2 major REP-types which 
consisted of 73.7% (n=14) of E. faecium isolates namely: type D (n=9) and type F (n=5). Of the 19 E. 
faecium isolates, 18 were from “farm,” and 1 was from “abattoir.” The clonal cluster D2 showed a 
similarity index of 100% and consisted of 5 isolates originating from faecal (Round 1) and wastewater 
(Round 2). There was less diversity in the source of E. faecium isolates.  Isolates belonging to the same 
REP-types were isolated from the farm and its environments (feces and wastewater) but there was 
minimal evidence of transmission along the farm-to-form continuum. 
Discussion 
This study presented the results of the molecular characteristics of Enterococcus spp. isolated from pigs 
in food production along the farm-to-fork continuum over 4 months in KwaZulu Natal, South Africa. 
A total of 284 isolates were obtained and real time-PCR confirmed 79.2% of the isolates as E. faecalis, 
6.7% as E. faecium, 2.5% as E. casseliflavus, 0.4% as E. gallinarum, and 11.2% as other Enterococcus 
spp. Antibiotic susceptibility testing revealed the highest resistance to sulfamethoxazole-trimethoprim 
(78.8%), tetracycline (76.9%), erythromycin (68.1%), and streptomycin (62.6 %) but no vancomycin, 
teicoplanin, tigecycline, or linezolid resistance. E. faecium displayed 44.4% resistance to quinupristin-
dalfopristin. A total of 78% of Enterococcal isolates were MDR. Phenotypic resistance to tetracycline, 
aminoglycosides, and macrolides was corroborated by the presence of the tetM, aph(3’)-IIIa, and ermB 
genes in 99.1%, 96.1%, and 88.3% of the isolates, respectively. The highest prevalence of virulence 
genes detected were: gelE (89.1%), efaAfs (78.5%), and cpd (77.1%). Clonality evaluated by REP-PCR 
revealed that E. faecalis isolates along the continuum are highly diverse, with major REP-types often 
consisting of isolates from the same sampling source but different sampling rounds (on the farm). In 
contrast, there was less diversity in the source of E. faecium isolates.  
The incidence of enterococci with high resistance rates has been increasing recently(Hollenbeck et al., 
2012; Iweriebor et al., 2015; Novais et al., 2013; Molechan et al., 2019). In the current study, the 
prevalence of E. faecalis (79.2%) dominated across all sampling points followed by undifferentiated 
Enterococcus species (11.2%) and E. faecium (6.7%). To a lesser extent, 2.5% and 0.4% of enterococcal 
isolates were identified as E. casseliflavus and E. gallinarum, respectively. Tan et al. (2018) conducted 
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a study in Malaysia which investigated the molecular epidemiology of 289 Enterococcus spp. recovered 
from pig (n=232), human (n=54) and environmental sources (n=3) from seven farms. Of this total, 73% 
and 25%, were identified as E. faecalis and E. faecium, respectively (Tan et al., 2018). Furthermore, a 
study done on two pig farms in Nigeria in 2016, revealed 268 enterococci isolates of which 79.5% were 
E. Faecalis and 20.5% were E. Faecium (Beshiru et al., 2017). In these studies, E. faecalis was the 
predominant species which is consistent with the present study  
In other works, E. faecium and was described as the more dominant species (Iweriebor et al., 2015; de 
Jong et al., 2019). The study done by de Jong et al. (2019) collected intestinal content from cattle, pigs, 
and chicken across Europe over 3 time periods. Out of 5334 Enterococcus strains recovered, 2435 E. 
faecium and 1389 E. faecalis were identified with 884 (36%) and 339 (24%) being isolated from pigs, 
respectively (de Jong et al., 2019). Within South Africa, one study conducted on two pig farms reported 
that the most dominant enterococcal species (n=320) recovered from faecal samples from pigs was E. 
faecium (37.5%) followed by E. hirae (31.25%) (Iweriebor et al., 2015). The reason for the relatively 
low prevalence of E. faecium (6.7%) in this study remains unclear. It may be possible to explain the 
differences in the composition of the enterococcal populations by the variation between geographical 
regions. However, it is difficult to draw firm conclusions that further highlights the significance of 
adding Enterococcus spp. in surveillance systems. 
All enterococcal isolates (100%) were susceptible to ampicillin, imipenem, teicoplanin, vancomycin, 
tigecycline, and linezolid. According to the WHO CIA List, these antibiotics are considered critically 
important in human health (WHO, 2019). Susceptibility to several critically important antibiotics was 
also observed in other studies (de Jong et al., 2018; Hasannejad et al., 2015). The “highest priority” 
critically important antibiotic of significance in this study is vancomycin, a glycopeptide (WHO, 2019). 
The absence of resistance to “critically important” antibiotics for human medicines such as linezolid, 
imipenem, tigecycline, and vancomycin is encouraging. It should be noted that tetracycline and tylosin 
(one of four growth promoters banned in the EU) are still approved as antibiotics for growth promotion 
under the Fertilizers, Farm Feeds, Agricultural Remedies and Stock Remedies Act (Act 36 of 1947) in 
South Africa. The majority of antibiotics consumed in food animals in South Africa include tetracycline, 
sulfonamides/trimethoprim, macrolides, penicillins, and cephalosporins, all of which are of direct 
importance in human medicine (Eagar, Swan and Van Vuuren, 2012). Perhaps the high levels of 
resistance, displayed in enterococcal isolates in this study, to tetracycline (76.9%), sulfamethoxazole-
trimethoprim (78.8%), erythromycin (68.1%) and streptomycin (62.6%) can be attributed to the 
extensive use of the above-mentioned antibiotics in food animals which exerts selection pressure for 
the development/escalation of resistance (Molechan et al., 2019).  
The most frequently encountered tetracycline resistant determinant in enterococci is tetM which is 
consistent with the findings in this study as a majority of isolates that were positive for the tetM gene 
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(99.1%) showed phenotypic tetracycline resistance. Overall, 78 enterococcal isolates (34.7%) 
harboured both tetM (ribosomal protection) and tetK (efflux pump) resistance genes. The transferability 
of tetracycline resistance determinants has been regularly associated with conjugative transposons, 
mainly Tn916/Tn1545 carrying the tetM gene, usually in combination with ermB, although it has also 
been reportedly found on plasmids (Ayeni et al., 2016; Torres et al., 2018). In this study, 181 
enterococcal isolates co-carried these genes.  The most reported erythromycin-resistant determinant in 
enterococci is ermB. While a majority of enterococcal isolates harboured the ermB gene (88.3%), E. 
faecalis accounted for 67.8% of isolates. It is possible that other genes could be associated with 
erythromycin- resistant enterococcal isolates, such as ermA, ermC, ermF,or ermT or the macrolide 
efflux pump (msrA) (Van Hoek et al., 2011).  
 
Enterococci have intrinsic low-level resistance to aminoglycosides. A synergistic bactericidal 
combination of a cell wall- active agents like penicillin or a glycopeptide, with an aminoglycoside is 
commonly used to treat enterococcal infections. Enterococci that have acquired aminoglycoside 
resistance challenge this treatment option by eliminating this synergistic effect. High level 
aminoglycoside resistance was detected in enterococcal isolates (streptomycin 62.6% (n=204) and 
gentamicin 14% (n=39)). Two isolates from the high-level gentamicin resistance (HLGR) phenotype 
showed the presence of aac(6’)-e-aph(2”)-Ia gene. It is possible that other genes such as aph(2’)-lc and 
aac(6’)-li could be associated with HLGR (Van Hoek et al., 2011). The aph(3’)-IIIa gene was detected 
in 96.1% of isolates with a high-level streptomycin resistance phenotype, which shows a close 
association between phenotypic resistance and resistance determinants. Antibiotic resistance to 
quinupristin-dalfopristin was observed in 78.9% (n=15) of E. faecium isolates. This is of importance as 
streptogramins such as quinupristin-dalfopristin are used for the treatment of severe VRE. faecium 
infections associated with bacteremia (Isnard et al., 2013).      
It is important to identify the potential virulence factors of enterococcal strains as they may help to 
understand the complex pathogenic activity of these opportunistic bacteria (Chajęcka-Wierzchowska, 
Zadernowska and Łaniewska-Trokenheim, 2017). E. faecalis (89.3%) and E. faecium (47.4%) were 
positive for their corresponding cell wall adhesin genes, efaAfs and efaAfm. Gelatinase (gelE) and sex 
pheromone (cpd) genes were prevalent while cytolysin (cylB and cylA) genes were detected to a lesser 
extent in E. faecalis and E. faecium. These genes confer pathogenicity by degrading host tissue and play 
a role in biofilm formation (gelE), promoting plasmid accumulation (cpd), haemolytic and bactericidal 
activity (cylB and cylA). This correlates with other studies that reported gelE gene as the most prevalent 
virulence determinant among E. faecalis isolates from pigs in China and Korea (Zou et al., 2011; In 
Yeong et al., 2011). Iweriebor et al. (2015) also reported the prevalence of gelE and ace genes from 
pigs in Eastern Cape, South Africa. It appears from this study that the incidence of virulence factors in 
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Enterococcus spp. is generally high, with majority of isolates carrying more than two virulence 
determinants (n=249; 87.7%).  
REP-PCR was used to distinguish clonal relatedness among Enterococcal isolates. MDR E. faecalis 
isolates were diverse with 35 REP-types (A-AI), while E. faecium isolates showed less diversity with 7 
REP-types (A-G). Concerning E. faecalis, it is interesting to note that REP-type T consisted of isolates 
from the farm that were ≥70% genetically related to those originating from the abattoir and retail meat. 
While this may suggest possible transmission of these isolates through the different stages of 
production, it must be noted that these isolates did not share the same resistance genes and virulence 
factors. REP-types Z, AH, AI comprised of faecal and wastewater isolates that were ≥70% genetically 
related, which may indicate possible enterococcal contamination of the associated environment. The 
outcome of “untreated wastewater and/or animal faeces on croplands could result in the dissemination 
of resistance and virulence determinants to home-grown soil bacteria via horizontal gene transfer, which 
could, in turn, disseminate resistance and virulence determinants back to animals or humans through 
crops” (Beshiru et al., 2017). This reinforces the necessity for a multisectoral approach for AMR 
surveillance programs. Furthermore, REP-type AI consisted of isolates from the farm that were ≥70% 
genetically related to those originating from the transport site. These isolates were obtained from truck 
swabs after the pigs were loaded onto the truck. This may indicate possible transfer from the pigs to the 
truck however, these isolates showed no clonal relation to isolates from further along the continuum – 
abattoir and retail - which may highlight the importance of biosecurity measures as in-house 
decontamination protocols on the truck would be necessary. However, further studies that involve the 
use of more resolute typing methods such whole genome sequencing (WGS) will be needed to validate 
these claims. In comparison, E. faecium isolates showed a less diverse evolutionary relationship. 
However, of the 19 isolates analysed, it should be noted that 68.4% (n=13) were MDR with 57.9% 
(n=11) harboring at least two virulence genes and 84.2% (n=16) harboring at least one antibiotic 
resistance gene.  
Conclusion 
This is the first study in South Africa to investigate the molecular epidemiology of Enterococcus spp. 
isolated from pigs in food production along the farm-to-fork continuum in KwaZulu Natal. The results 
of this study highlight the prevalence of enterococcal species and MDR Enterococcus isolates which 
harbour resistance determinants that can serve as reservoirs for the possible transfer of these 
determinants  from pigs to humans. The results highlight the importance of more robust guidelines for 
antibiotic use in intensive farming practices and the necessity of including Enterococcus spp. in food 
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                                      Antibiotic resistance genes 
 
ermB (n=205) aph(3')-IIIa (n=204) tetK (n=228) tetM (n=228) aac(6')-Ie-aph(2")-
Ia (n=39) 
E. faecalis  139 (67.8%) 155 (76.0%) 35 (15.4%) 177 (77.6%) 2 (5.1%) 
E. faecium  13 (6.3%) 11 (5.4%) 1 (0.4%) 11 (4.8%) 0 (0.0%) 
E. casseliflavus  2 (1.0%) 4 (2.0%) 0 (0.0%) 6 (2.6%) 0 (0.0%) 
E. gallinarum  1 (0.5%) 0 (0.0%) 0 (0.0%) 1 (0.4%) 0 (0.0%) 
Other Enterococcus 
spp.  
26 (12.7%) 26 (12.7%) 3 (1.3%) 31 (13.6%) 0 (0.0%) 
Total  181 (88.3%) 196 (96.1%) 39 (17.1%) 226 (99.1%) 2 (5.1%) 
 









efaAfs gelE cpd cylB cylA efaAfm 
E. faecalis (n=225) 201 (89.3%) 208 (92.4%) 186 (82.7%) 80 (35.6%) 49 (21.8%) 1 (0.4%) 
E. faecium (n=19) 0 (0.0%) 13 (68.4%) 10 (52.6%) 1 (5.3%) 0 (0.0%) 9 (47.4%) 
E. casseliflavus (n=7) 3 (42.9%) 5 (71.4%) 2 (28.6%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 
E. gallinarum (n=1) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 
Other Enterococcus spp. 
(n=32) 
19 (59.4%) 27 (84.4%) 21 (65.6%) 8 (25.0%) 3 (9.4%) 0 (0.0%) 






Figure 4: Dendrogram showing REP-types of E. faecium isolates, based on ≥70% similarity index 

























































































































E. faecium ATCC 700221 
E. faecium 




Arias, C. A., & Murray, B. E. (2012). The rise of the Enterococcus: Beyond vancomycin resistance. Nature 
Reviews Microbiology. 10 (4). pp. 266-278. 
Ayeni, F. A., Odumosu, B. T., Oluseyi, A. E., & Ruppitsch, W. (2016). Identification and prevalence of 
tetracycline resistance in enterococci isolated from poultry in Ilishan, Ogun State, Nigeria. Journal 
of Pharmacy & Bioallied Sciences. 8(1). pp. 69–73. 
Beshiru, A., Igbinosa, I., Omeje, F., Ogofure, A., Eyong, M. and Igbinosa, E. (2017) Multi-antibiotic 
resistant and putative virulence gene signatures in Enterococcus species isolated from pig farms 
environment. Microbial Pathogenesis, 104, pp. 90-96. 
Chajęcka-Wierzchowska, W., Zadernowska, A. and Łaniewska-Trokenheim, Ł. (2017) Virulence factors 
of Enterococcus spp. presented in food. LWT, 75, pp. 670-676. 
Clinical and Laboratory Standards Institute (CLSI) (2017). Performance standards for antimicrobial 
susceptibility testing. CLSI supplement M100. 27th Ed. Wayne, Pennsylvania. 
de Jong, A., Simjee, S., Garch, F. El, Moyaert, H., Rose, M., Youala, M. & Dry, M. (2018). Antimicrobial 
susceptibility of enterococci recovered from healthy cattle, pigs and chickens in nine EU countries 
(EASSA Study) to critically important antibiotics. Veterinary Microbiology. 216. pp. 168–175. 
de Jong, A., Simjee, S., Rose, M., Moyaert, H., El Garch, F., Youala, M., Marion, O., Lin, D., Filip, B., 
Mireille, B., Bénédicte, C., Jeroen, D., Sophie, G., Szilárd, J., Isabelle, K., Lourdes, M., Mogens, M., 
Caroline, P., Ellen, P., Hanna, R., Pascal, S., Kees, V., Dariusz, W., Peter, W., Pascal, B., Silke, H., 
Ulrich, K., Terence, P., Guido, S., Pieter-Jan, S. and Thais, V (2019) Antimicrobial resistance 
monitoring in commensal enterococci from healthy cattle, pigs and chickens across Europe during 
2004–14 (EASSA Study). Journal of Antimicrobial Chemotherapy, 74(4), pp. 921-930. 
Eagar, H., Swan, G. and Van Vuuren, M. (2012) A survey of antimicrobial usage in animals in South Africa 
with specific reference to food animals. Journal of the South African Veterinary Association, 83(1). 
pp. 1-8. 
European Committee on Antimicrobial Susceptibility Testing (EUCAST) (2017). Breakpoint tables for 
interpretation of MICs and zone diameters. Version 7.0, 2017. http://www.eucast.org. 
Fisher, K. & Phillips, C. (2009). The ecology, epidemiology and virulence of Enterococcus. Microbiology. 
155 (6). pp. 1749–1757. 
52 
 
Food and Agriculture Organization (United Nations) (FAO) (2016). The FAO action plan on antimicrobial 
resistance: Supporting the food and agriculture sectors in implementing the Global Action Plan on 
Antimicrobial Resistance to minimize the impact of antimicrobial resistance. Rome, Italy. 
Hasannejad, B. M., Eshaghi M., Sadeghi J., Asadian M., Narimani T., Talebi M. (2015). Clonal Diversity 
in Multi Drug Resistant (MDR) Enterococci Isolated from Fecal Normal Flora. International Journal 
of Molecular and Cellular Medicine. 4(4). pp. 240-244  
Hollenbeck, B.L. & Rice, L.B. (2012). Intrinsic and acquired resistance mechanisms in Enterococcus. 
Virulence. 3 (5). pp. 421–569. 
In Yeong, H., Kyung Lim, S., Ok Ku, H., Kyu Park, C., Chan Jung, S., Ho Park, Y. and Mi Nam, H. (2011) 
Occurrence of Virulence Determinants in Fecal Enterococcus faecalis Isolated from Pigs and 
Chickens in Korea. Journal of Microbiology and Biotechnology, 21(12). pp. 1352-1355. 
Isnard, C., Malbruny, B., Leclercq, R. & Cattoir, V. (2013). Genetic basis for in vitro and in vivo resistance 
to lincosamides, streptogramins A, and pleuromutilins (LSAP phenotype) in Enterococcus faecium. 
Antimicrobial Agents and Chemotherapy. 57 (9). pp. 4463–4469. 
Iweriebor, B.C., Obi, L.C. & Okoh, A.I. (2015). Virulence and antimicrobial resistance factors of 
Enterococcus spp. isolated from fecal samples from piggery farms in Eastern Cape, South Africa. 
BMC Microbiology. 15 (136). pp. 1-11. 
Kaye, K. S., Engemann, J. J., Fraimow, H. S., & Abrutyn, E. (2004). Pathogens resistant to antimicrobial 
agents: Epidemiology, molecular mechanisms, and clinical management. Infectious Disease Clinics 
of North America. 18(1). pp. 467-511  
Landers, T.F., Cohen, B., Wittum, T.E., & Larson, E.L. (2012). A review of antibiotic use in food animals: 
perspective, policy, and potential. Public Health Reports, 127(1), pp. 4–22.  
Molechan, C., Amoako, D., Abia, A., Somboro, A., Bester, L. and Essack, S. (2019). Molecular 
epidemiology of antibiotic-resistant Enterococcus spp. from the farm-to-fork continuum in intensive 
poultry production in KwaZulu-Natal, South Africa. Science of the Total Environment. 692, pp. 868-
878. 
Novais, C., Freitas, A., Silveira, E., Antunes, P., Silva, R., Coque, T. and Peixe, L. (2013). Spread of 
multidrug-resistant Enterococcus to animals and humans: an underestimated role for the pig farm 
environment. Journal of Antimicrobial Chemotherapy, 68(12), pp. 2746-2754. 
53 
 
Quiloan, M. L. G., Vu, J., & Carvalho, J. (2012). Enterococcus faecalis can be distinguished from 
Enterococcus faecium via differential susceptibility to antibiotics and growth and fermentation 
characteristics on mannitol salt agar. Frontiers in Biology, 7(2), pp. 167–177. 
Tan, S.C., Chong, C.W., Teh, C.S.J., Ooi, P.T. & Thong, K.L. (2018). Occurrence of virulent multidrug-
resistant Enterococcus faecalis and Enterococcus faecium in the pigs, farmers and farm environments 
in Malaysia. PeerJ. 6, e5353. 
Torres, C., Alonso, C. A., Ruiz-Ripa, L., León-Sampedro, R., Del Campo, R., & Coque, T. M. 
(2018). Antimicrobial Resistance in Enterococcus spp. of animal origin. Microbiology Spectrum. 6 
(4), pp 1-41 
Van Boeckel, T.P., Brower, C., Gilbert, M., Grenfell, B.T., Levin, S.A., Robinson, T.P., Teillant, A. & 
Laxminarayan, R. (2015). Global trends in antimicrobial use in food animals. Proceedings of the 
National Academy of Sciences of the United States of America. 112(18), pp. 5649–5654. 
World Health Organization (WHO) (2015). Global action plan on antimicrobial resistance. Geneva, 
Switzerland. 
World Health Organization (WHO) (2017). WHO Integrated surveillance of antimicrobial resistance in 
foodborne bacteria. Geneva, Switzerland. 
World Organization for Animal Health (OIE) (2016). The OIE Strategy on Antimicrobial Resistance and 
the Prudent Use of Antimicrobials. Paris, France. 
ou, Y. & Silbergeld, E.K. (2014). Learning from agriculture: understanding low-dose antimicrobials as 
drivers of resistome expansion. Frontiers in Microbiology. 5(284), pp. 1-10. 
Zou, L.-K., Wang, H.-N., Zeng, B., Li, J.-N., Li, X.-T., Zhang, A.-Y., Zhou, Y.-S., Yang, X., Xu, C.-W. & 
Xia, Q.-Q. (2011). Erythromycin resistance and virulence genes in Enterococcus faecalis from swine 



















Table S1: List of controls and primers used in molecular genus and species confirmation. 
Control Strain   Primer Primer sequence (5'-3') Product size (bp) 




























Reference: (Molechan et al., 2019) 
*Field strains were provided by the National Health Laboratory Services (NHLS), South Africa 
Table S2: List of antibiotic resistance genes primers 
Gene Description Positive control strains  Primer sequence (5'-3') 
tetK Tetracycline resistance 
  
S. aureus clinical strain * 
F- TTAGGTGAAGGGTTAGGTCC 
R-GCAAACTCATTCCAGAAGCA 

















resistance E. faecalis ATCC 51299 
F- GGCTAAAATGAGAATATCACCGG 
R- CTTTAAAAAATCATACAGCTCGCG 
Reference: (Molechan et al., 2019) 







Table S3: List of virulence genes primers 
Gene Description Control strains Primer sequence (5'-3') 
gelE 



















efaAfs Cell wall adhesins 






















3.1 Conclusions  
The following conclusions were drawn from this study: 
• A total of 284 isolates were obtained. 
• Real-time PCR confirmed enterococcal isolates: 79.2% as E. faecalis, 6.7% as E. faecium, 2.5% as 
E. casseliflavus, 0.4% as E. gallinarum and 11.2% as other Enterococcus spp.  
• Antibiotic susceptibility testing revealed resistance to sulfamethoxazole-trimethoprim (78.8%), 
tetracycline (76.9%), erythromycin (68.1%), streptomycin (62.6%), chloramphenicol (27.0%), 
ciprofloxacin (8.5%), gentamicin (8.1%), and levofloxacin (5,6%) but no vancomycin, teicoplanin, 
tigecycline or linezolid resistance. E. faecium displayed 44.4% resistance to quinupristin-
dalfopristin.  
• A total of 78% of Enterococcal isolates were MDR. 
• Phenotypic resistance to tetracycline, aminoglycosides and macrolides was corroborated by the 
presence of the tetM, aph(3’)-IIIa, and ermB genes in 99.1%, 96.1% and 88.3% of the isolates 
respectively.  
• The highest prevalence of virulence genes detected were: gelE (89.1%), efaAfs (78.5%), and cpd 
(77.1%). 
• Clonality evaluated by REP-PCR revealed that E. faecalis isolates along the continuum are highly 
diverse with major REP-types often consisting of isolates from the same sampling source but 
different sampling rounds (on the farm).  In contrast, there was less diversity in the source of E. 
faecium isolates.  
 
3.2 Limitations 
• In this study, 11% of isolates were undifferentiated to the species level. 
• The study sample was limited to a single farm and its associated abattoir in Kwa-Zulu Natal hence 
the results cannot be extrapolated to the whole of Kwa-Zulu Natal. 
 
3.3 Recommendations 
• Molecular confirmation of isolates to a species level should include E. hirae and E. durans as they 
have also been reported in pigs.  
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• To gain better understanding of the prevalence of virulence determinants present in isolates, 
additional virulence genes such as asa, hyl and esp should be studied.  
• Whole-genome sequencing should be considered for a comprehensive representation of genomic 
profiles. 
• More robust clonal typing methods should be used to elucidate the clonal complexes. 
• To gain sufficient data to inform strategies for the containment of antibiotic resistance as well as 
gauge the burden of MDR enterococci on pig farms, further studies in the pig production system 
should be conducted, with a consideration of choosing farms from different geographical locations 






















Appendix 3: Department of Agriculture, Forestry and Fisheries (DAFF) Section 20 Approval 


